Cullell, Natalia http://orcid.org/0000-0001-5118-1014
Carrera, Caty
Muiño, Elena
Torres-Aguila, Nuria-Paz
Cárcel-Márquez, Jara
González-Sánchez, Jonathan
Gallego-Fabrega, Cristina
Molina, Jessica
Besora, Sarah
Sotoca, Javier
Buongiorno, Maria-Teresa
Jiménez-Conde, Jordi
Giralt-Steinhauer, Eva
de Torres-Chacón, Reyes
Montaner, Joan
Mancha, Fernando http://orcid.org/0000-0003-0310-0894
Cabezas, Juan A
Martí-Fàbregas, Joan http://orcid.org/0000-0001-9229-8649
Prats-Sánchez, Luis
Camps-Renom, Pol http://orcid.org/0000-0001-6587-6271
Purroy, Francisco http://orcid.org/0000-0002-1808-5968
Cambray, Serafi
Freijo, María del Mar
Vives-Bauzá, Cristòfol
Tur, Silvia
Font, Maria-Àngels
López-Cancio, Elena
Hernandez-Perez, Maria
Obach, Victor
Calleja, Ana
Arenillas, Juan
Rodríguez-Yáñez, Manuel
Castillo, José
Sobrino, Tomas
Fernández-Cádenas, Israel
Krupinski, Jerzy
Funding for this research was provided by:
Boehringer Ingelheim Fonds (JKB-DAB-01, JKB-DAB-01, JKB-DAB-01)
Article History
Received: 24 September 2019
Accepted: 8 January 2020
First Online: 18 February 2020
Competing interests
: Boehringer Ingelheim has financially supported this study through the SEDMAN study and the EPIGENESIS and MAESTRO studies funded by the Carlos III Health Institute and MaratoTV3 foundation. I.F.-C. and T.S. are supported by a Miguel Servet II contract from the Carlos III Health Institute. I.F.-C., J.K. and N.C. have competing interest with Boehringer Ingelheim related to the signed contract for SEDMAN study